NCT00817752View on ClinicalTrials.gov

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
InflammationCancerAutoimmune Diseases
Interventions
DIETARY_SUPPLEMENT

Ashwagandha

Participants consume 3mL of Ashwagandha for 5 days. Blood work/immune cells (CD4 T-cells, CD8 T-cells, B-cells, NK cells, macrophages, IL-1, IL-6 and TNF-alpha) and psychological assessments (POMS and STAI Self-Evaluation) given at specified time intervals.

Trial Locations (1)

97201

Helfgott Research Institute, Portland

Sponsors
All Listed Sponsors
collaborator

Helfgott Research Institute

UNKNOWN

lead

National University of Natural Medicine

OTHER